How obesity affects cancer treatment in endometrial cancer patients
Official title: Impact of Obesity on Immuno-Oncology Agents in Endometrial Cancer
Funded at Univ of North Carolina Chapel Hill · NIH-10672881 · Data updated 2026-11-12
This study is looking at how being overweight affects the success of certain cancer treatments for women with endometrial cancer, and it aims to find better ways to help those patients by combining two specific medications.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | August 1, 2022 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $172,653 |
| NIH project number | 5R21CA267584-02 |
| Project ID | NIH-10672881 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are obese patients diagnosed with endometrial cancer.
✕Less likely to help
Patients who are not obese or do not have endometrial cancer may not benefit from this research.
What this research studies
This research investigates the impact of obesity on the effectiveness of immuno-oncology treatments for endometrial cancer. It focuses on how obesity influences the immune response and the expression of specific proteins that are targeted by cancer therapies. The study will explore the combination of atezolizumab, an anti-PD-L1 antibody, with ONC201, a small molecule that may enhance treatment efficacy. By understanding these interactions, the research aims to improve treatment outcomes for obese patients with endometrial cancer.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments for obese patients with endometrial cancer.
How similar studies have gone: Other research has shown promising results with immuno-oncology treatments in similar contexts, but this specific approach is relatively novel.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Bae-Jump, Victoria Lin — Univ of North Carolina Chapel Hill
- Study coordinator: Bae-Jump, Victoria Lin
Related research
Other NIH-funded projects on the same topics.
-
Obesity-related metabolic changes and disparities in endometrial cancer
This project looks at why endometrial cancer is worse for Black women and whether obesity-related metabolic changes drive the disease, with aims to find ways to prevent or slow progression.
-
Investigating how obesity affects protein quality control in endometrial cancer
This study is looking at how being overweight might affect the way cancer cells in the uterus work, especially in women with endometrial cancer, to help find better ways to prevent and treat this type of cancer.
-
Investigating how progesterone receptors work in obesity to prevent endometrial cancer
This study is looking at how being overweight might affect the way certain hormones work in the uterus, especially in women at risk for endometrial cancer, to find out how we can better prevent this type of cancer.
-
Investigating how obesity affects the response to metformin in endometrial cancer
This study is looking at how the diabetes medication metformin might help treat endometrial cancer in people with obesity and diabetes, and it aims to find out which patients could benefit the most from this treatment.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Understanding how maternal and infant sleep and daily rhythms influence early appetite and obesity risk
This project explores how infant sleep, circadian rhythms, and maternal-infant timing relate to early appetite patterns and the risk of obesity in the first year of life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.